02.03.2013 Views

Target Discovery and Validation Reviews and Protocols

Target Discovery and Validation Reviews and Protocols

Target Discovery and Validation Reviews and Protocols

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Transgenic Models 189<br />

(142). Genes whose expression is amplified in mammary tumors (c-myc, crbB2,<br />

<strong>and</strong> cyclin D1) have an oncogenic effect when used as transgenes. Crossing mice<br />

harboring different oncogenes <strong>and</strong> having knocked-out genes has made it possible<br />

to determine the cooperative actions of some of these genes.<br />

Mice having knocked-out cyclin D1 gene are insensitive to neu <strong>and</strong> ras oncogenes,<br />

whereas Wnt-1 <strong>and</strong> c-myc genes have kept their capacity to trigger mammary<br />

tumors. These data help to search for new drugs capable of inhibiting neu,<br />

ras, <strong>and</strong> cyclin D1 genes (143,144).<br />

The stability of mammary epithelial cells is highly dependent on the extracellular<br />

matrix. Development of mammary tumors <strong>and</strong> metastasis are correlated<br />

with local degradation of some of the extracellular matrix components.<br />

Degradation of the extracellular matrix is achieved by metalloproteinases, which<br />

are controlled by specific inhibitors. The role of different genes involved in<br />

extracellular matrix synthesis <strong>and</strong> degradation is being studied using transgenic<br />

mouse models. A recent study has pointed out the role of Akt gene, which delays<br />

mammary gl<strong>and</strong> involution. This effect is mediated by the prolonged presence of<br />

one of the metalloproteinase inhibitors (145). A better underst<strong>and</strong>ing of these<br />

phenomena may lead to the identification of new drugs preventing metastasis.<br />

It is agreed that tumor cells derive from a single cell in which all the mutations<br />

required for cancer development occurred, thereby explaining in part why<br />

cancer development is a slow process at the early steps <strong>and</strong> becomes rapid in<br />

time. The classical transgenic models do not take into account the fundamental<br />

clonal origin of cancers. Specific gene constructs capable of sporadically activating<br />

oncogenes have been designed (146). The technique makes it possible to<br />

activate k-ras oncogene r<strong>and</strong>omly <strong>and</strong> at a low frequency (147). This new<br />

approach is expected to reflect more precisely the process of tumor formation<br />

under natural conditions.<br />

4.7. Models for Infectious Diseases<br />

Many pathogens have species specificity, <strong>and</strong> conventional laboratory animals<br />

may not be relevant models. The limitation is often because of the lack of<br />

appropriate receptors for the pathogens in the animal cells. Receptor genes can<br />

then be transferred to animals to be preferentially expressed in tissues, which<br />

are the normal target of the pathogens.<br />

Listeria monocytogenes is responsible for severe foodborne infections. A<br />

surface protein of these bacteria, called internalin, has been generated that recognizes<br />

the intestinal host receptor E-cadherin gene exclusively in the enterocytes<br />

of the small intestine. This recognition was achieved by using the<br />

promoter from the rat FABP-1 gene. These mice were sensitive to infection by<br />

L. monocytogenes <strong>and</strong> constitute an excellent model for the study of this infectious<br />

pathogen. Interestingly, E-cadherin is not expressed in the tight junction

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!